AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2015 to Q1 2024

Type / Class
Equity / SPONSORED ADR
Symbol
AKTX on Nasdaq
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of AKARI THERAPEUTICS PLC - SPONSORED ADR (AKTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2024 Q1 0 $0 -$511,777 0
2023 Q4 164,031 $511,777 -$43,867 $3.16 2
2023 Q3 178,091 $703,459 -$28,951,637 $3.95 1
2023 Q2 10,076,550 $1,712,859 -$7,296 $0.17 16
2023 Q1 10,120,691 $1,839,174 -$794,013 $0.18 11
2022 Q4 8,922,318 $4,193,343 -$562,753 $0.47 15
2022 Q3 10,113,790 $6,372,000 +$5,289,224 $0.63 13
2022 Q2 1,682,178 $1,682,000 +$97,213 $1.00 14
2022 Q1 1,575,861 $1,892,000 +$159,511 $1.20 11
2021 Q4 1,442,780 $2,163,000 +$321,557 $1.50 11
2021 Q3 1,220,629 $1,990,000 -$152,097 $1.64 14
2021 Q2 1,313,557 $2,271,000 -$547,315 $1.73 12
2021 Q1 1,477,285 $3,899,000 -$100,080 $2.64 12
2020 Q4 1,582,523 $2,929,430 +$241,967 $1.85 11
2020 Q3 1,458,043 $2,535,000 -$2,566,221 $1.74 12
2020 Q2 2,909,034 $6,339,653 +$1,319,917 $2.18 19
2020 Q1 2,306,055 $3,345,000 -$97,401 $1.45 10
2019 Q4 2,369,436 $4,147,000 +$360,120 $1.75 12
2019 Q3 2,165,845 $3,701,000 -$703,455 $1.68 10
2019 Q2 2,488,461 $5,026,000 +$188,175 $2.02 9
2019 Q1 2,361,876 $8,456,000 +$1,081,865 $3.58 12
2018 Q4 2,072,086 $3,254,000 -$171,220 $1.57 7
2018 Q3 2,050,744 $5,250,000 +$221,373 $2.56 10
2018 Q2 1,986,386 $3,875,000 -$379,906 $1.95 10
2018 Q1 2,179,812 $3,967,000 -$7,436,231 $1.82 8
2017 Q4 3,877,213 $16,792,000 +$6,111,087 $4.33 19
2017 Q3 2,465,693 $15,138,000 -$3,893,771 $6.14 12
2017 Q2 3,160,151 $14,489,000 -$1,865,844 $4.61 15
2017 Q1 3,376,632 $36,950,000 -$3,346,336 $11.07 12
2016 Q4 3,961,951 $27,524,000 -$332,044 $7.04 16
2016 Q3 4,005,099 $33,670,000 -$1,999,965 $8.51 18
2016 Q2 4,202,288 $56,033,000 +$5,396,022 $13.49 20
2016 Q1 1,175,940 $14,838,000 -$2,899,958 $12.14 11
2015 Q4 3,407,302 $49,220,000 -$644,358 $14.50 19
2015 Q3 2,646,851 $63,512,000 +$63,512,000 $24.00 14